1. Home
  2. AMPH vs RXST Comparison

AMPH vs RXST Comparison

Compare AMPH & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • RXST
  • Stock Information
  • Founded
  • AMPH 1996
  • RXST 1997
  • Country
  • AMPH United States
  • RXST United States
  • Employees
  • AMPH N/A
  • RXST N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AMPH Health Care
  • RXST Health Care
  • Exchange
  • AMPH Nasdaq
  • RXST Nasdaq
  • Market Cap
  • AMPH 2.5B
  • RXST 2.0B
  • IPO Year
  • AMPH 2014
  • RXST 2021
  • Fundamental
  • Price
  • AMPH $44.55
  • RXST $45.05
  • Analyst Decision
  • AMPH Buy
  • RXST Strong Buy
  • Analyst Count
  • AMPH 4
  • RXST 8
  • Target Price
  • AMPH $63.00
  • RXST $61.63
  • AVG Volume (30 Days)
  • AMPH 404.9K
  • RXST 673.6K
  • Earning Date
  • AMPH 11-06-2024
  • RXST 11-07-2024
  • Dividend Yield
  • AMPH N/A
  • RXST N/A
  • EPS Growth
  • AMPH 17.38
  • RXST N/A
  • EPS
  • AMPH 3.01
  • RXST N/A
  • Revenue
  • AMPH $723,549,000.00
  • RXST $128,293,000.00
  • Revenue This Year
  • AMPH $17.23
  • RXST $60.19
  • Revenue Next Year
  • AMPH $10.25
  • RXST $34.96
  • P/E Ratio
  • AMPH $14.78
  • RXST N/A
  • Revenue Growth
  • AMPH 20.33
  • RXST 67.52
  • 52 Week Low
  • AMPH $36.56
  • RXST $28.54
  • 52 Week High
  • AMPH $65.92
  • RXST $66.54
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 38.65
  • RXST 37.96
  • Support Level
  • AMPH $43.09
  • RXST $43.98
  • Resistance Level
  • AMPH $49.53
  • RXST $46.81
  • Average True Range (ATR)
  • AMPH 1.76
  • RXST 2.39
  • MACD
  • AMPH -0.62
  • RXST -0.40
  • Stochastic Oscillator
  • AMPH 13.43
  • RXST 19.20

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: